Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
4.94T | 4.83T | 3.83T | 3.12T | 2.88T | 3.43T | Gross Profit |
1.08T | 1.04T | 801.52B | 687.70B | 613.64B | 746.64B | EBIT |
270.84B | 250.50B | 141.97B | 101.84B | 8.82B | 43.60B | EBITDA |
385.71B | 419.51B | 247.92B | 192.12B | 98.58B | 135.87B | Net Income Common Stockholders |
220.27B | 207.70B | 142.81B | 81.56B | -31.65B | 12.13B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
922.56B | 922.56B | 717.10B | 740.39B | 739.00B | 568.96B | Total Assets |
3.79T | 3.79T | 3.26T | 2.97T | 2.92T | 2.79T | Total Debt |
575.79B | 575.79B | 627.13B | 680.81B | 755.93B | 619.87B | Net Debt |
-242.77B | -242.77B | -89.97B | -59.58B | 17.14B | 51.87B | Total Liabilities |
2.03T | 2.03T | 1.80T | 1.65T | 1.72T | 1.58T | Stockholders Equity |
1.74T | 1.74T | 1.44T | 1.30T | 1.18T | 1.18T |
Cash Flow | Free Cash Flow | ||||
306.06B | 303.65B | 38.30B | 49.80B | 34.02B | -87.52B | Operating Cash Flow |
416.64B | 418.89B | 137.42B | 189.16B | 120.06B | 34.83B | Investing Cash Flow |
-171.28B | -179.89B | -99.43B | -136.24B | -78.86B | -127.58B | Financing Cash Flow |
-38.98B | -84.70B | -89.86B | -86.41B | 99.35B | -24.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $42.95B | 8.65 | 11.47% | 6.98% | 3.03% | 28.54% | |
75 Outperform | $241.20B | 7.86 | 13.36% | 2.63% | -0.59% | 7.56% | |
75 Outperform | $3.79B | 4.99 | 6.30% | 4.32% | -2.11% | -39.87% | |
74 Outperform | $47.19B | 8.31 | 6.54% | 4.13% | 4.37% | 6.93% | |
71 Outperform | $48.10B | 7.26 | 8.88% | 0.96% | 7.76% | -14.17% | |
62 Neutral | $6.98B | 11.38 | 2.86% | 3.90% | 2.64% | -22.07% | |
48 Neutral | $8.22B | ― | -142.49% | ― | 16.99% | 12.99% |